FDA and NIH’s New Guidance

Organoids in the Spotlight: What FDA and NIH’s New Guidance Means FOR IMMEDIATE RELEASE July 2025 Ann Arbor, MI — In the past year, both the FDA and NIH have announced major policy shifts that signal a clear direction for the future of drug development: a move away...

2025 Activate Fellow

Intero CEO Charlie Childs Named 2025 Activate Fellow FOR IMMEDIATE RELEASE June 11, 2025 Ann Arbor, MI — We’re proud to announce that Intero Biosystems’ CEO and co-founder, Charlie Childs Ph.D., has been selected as a member of the Activate Fellowship’s 2025 cohort....

Press Release – June 11th, 2025

Intero Biosystems Closes Oversubscribed $2M Pre-Seed Round to Advance Human Intestinal Organoid Platform for Drug Discovery FOR IMMEDIATE RELEASE June 11, 2025 Ann Arbor, MI — Intero Biosystems, a biotechnology startup spun out of the University of Michigan, today...

Rice Business Plan Competition

Intero Biosystems Wins First Place and Over $900K at the Rice Business Plan Competition FOR IMMEDIATE RELEASE April 15, 2025 Ann Arbor, MI — We’re excited to share that Intero Biosystems was awarded first place and more than $900,000 in investment prizes at the 2025...